Over the past decade, we have seen an unparalleled growth in our knowledge of cancer biology and the translation of this biology into a new generation of therapeutic tools that are changing cancer treatment outcomes. With the continued explosion of new biologic discoveries, we find ourselves with a limited number of trained and engaged translational physician-scientists capable of bridging the chasm between basic science and clinical science. Here, we discuss the current state translational physician-scientists find themselves in and offer solutions to navigate during this difficult time.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Furuya, H., Brenner, D., & Rosser, C. J. (2017, May 1). On the brink of extinction: The future of translational physician-scientists in the United States. Journal of Translational Medicine. BioMed Central Ltd. https://doi.org/10.1186/s12967-017-1188-6